{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:52:39Z","timestamp":1787003559151,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75757-8","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T10:04:04Z","timestamp":1729677844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sacubitril\/valsartan improves diastolic left ventricular stiffness with increased titin phosphorylation via cGMP-PKG activation in diabetic mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Nozomi","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzo","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideru","family":"Obinata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kurabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimichi","family":"Koitabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"75757_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65nrcardio.2017.65[pii]","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay, S. M., Roger, V. L. & Redfield, M. M. Epidemiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 14, 591\u2013602. https:\/\/doi.org\/10.1038\/nrcardio.2017.65nrcardio.2017.65[pii] (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"75757_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1161\/01.cir.0000048123.22359.a0","volume":"107","author":"M Kawaguchi","year":"2003","unstructured":"Kawaguchi, M., Hay, I., Fetics, B. & Kass, D. A. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107, 714\u2013720. https:\/\/doi.org\/10.1161\/01.cir.0000048123.22359.a0 (2003).","journal-title":"Circulation"},{"key":"75757_CR3","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa032566","volume":"350","author":"MR Zile","year":"2004","unstructured":"Zile, M. R., Baicu, C. F. & Gaasch, W. H. Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 350, 1953\u20131959. https:\/\/doi.org\/10.1056\/NEJMoa032566 (2004).","journal-title":"N. Engl. J. Med."},{"key":"75757_CR4","doi-asserted-by":"publisher","first-page":"H501","DOI":"10.1152\/ajpheart.00138.2005","volume":"289","author":"D Burkhoff","year":"2005","unstructured":"Burkhoff, D., Mirsky, I. & Suga, H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am. J. Physiol. Heart Circ. Physiol. 289, H501-512. https:\/\/doi.org\/10.1152\/ajpheart.00138.2005 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"75757_CR5","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","volume":"131","author":"MR Zile","year":"2015","unstructured":"Zile, M. R. et al. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation 131, 1247\u20131259. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013215 (2015).","journal-title":"Circulation"},{"key":"75757_CR6","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.107.716886","volume":"117","author":"D Westermann","year":"2008","unstructured":"Westermann, D. et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 117, 2051\u20132060. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.716886 (2008).","journal-title":"Circulation"},{"key":"75757_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2016.07.025","volume":"182","author":"JB Echouffo-Tcheugui","year":"2016","unstructured":"Echouffo-Tcheugui, J. B. et al. Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from get with the guidelines-heart failure registry. Am. Heart J. 182, 9\u201320. https:\/\/doi.org\/10.1016\/j.ahj.2016.07.025 (2016).","journal-title":"Am. Heart J."},{"key":"75757_CR8","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/01.cir.103.22.2668","volume":"103","author":"C Iribarren","year":"2001","unstructured":"Iribarren, C. et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 103, 2668\u20132673. https:\/\/doi.org\/10.1161\/01.cir.103.22.2668 (2001).","journal-title":"Circulation"},{"key":"75757_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","volume":"135","author":"SL Kristensen","year":"2017","unstructured":"Kristensen, S. L. et al. Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction: a report from the i-preserve trial (irbesartan in heart failure with preserved ejection fraction). Circulation 135, 724\u2013735 (2017).","journal-title":"Circulation"},{"key":"75757_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","volume":"71","author":"TH Marwick","year":"2018","unstructured":"Marwick, T. H., Ritchie, R., Shaw, J. E. & Kaye, D. Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 71, 339\u2013351. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.019 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"75757_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","volume":"124","author":"WH Dillmann","year":"2019","unstructured":"Dillmann, W. H. Diabetic cardiomyopathy. Circ. Res. 124, 1160\u20131162. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.314665 (2019).","journal-title":"Circ. Res."},{"key":"75757_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/CIRCRESAHA.117.312166","volume":"123","author":"AE Hopf","year":"2018","unstructured":"Hopf, A. E. et al. Diabetes-induced cardiomyocyte passive stiffening is caused by impaired insulin-dependent titin modification and can be modulated by neuregulin-1. Circ. Res. 123, 342\u2013355. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312166 (2018).","journal-title":"Circ. Res."},{"key":"75757_CR13","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker, S. D. et al. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMoa2107038 (2021).","journal-title":"N. Engl. J. Med."},{"key":"75757_CR14","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon, S. D. et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N. Engl. J. Med. 381, 1609\u20131620. https:\/\/doi.org\/10.1056\/NEJMoa1908655 (2019).","journal-title":"N. Engl. J. Med."},{"key":"75757_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ejhf.799","volume":"19","author":"E D'Elia","year":"2017","unstructured":"D\u2019Elia, E. et al. Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides. Eur. J. Heart Fail 19, 710\u2013717. https:\/\/doi.org\/10.1002\/ejhf.799 (2017).","journal-title":"Eur. J. Heart Fail"},{"key":"75757_CR16","doi-asserted-by":"publisher","first-page":"139910","DOI":"10.1172\/jci.insight.139910e139910","volume":"5","author":"K Michel","year":"2020","unstructured":"Michel, K. et al. C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness. JCI Insight 5, 139910. https:\/\/doi.org\/10.1172\/jci.insight.139910e139910 (2020).","journal-title":"JCI Insight"},{"key":"75757_CR17","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1161\/CIRCRESAHA.122.320882","volume":"130","author":"T Michel","year":"2022","unstructured":"Michel, T. et al. proANP metabolism provides new insights into sacubitril\/valsartan mode of action. Circ. Res. 130, e44\u2013e57. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.320882 (2022).","journal-title":"Circ. Res."},{"key":"75757_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-021-01270-180","volume":"20","author":"AR Aroor","year":"2021","unstructured":"Aroor, A. R. et al. Sacubitril\/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness. Cardiovasc. Diabetol. 20, 80. https:\/\/doi.org\/10.1186\/s12933-021-01270-180 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"75757_CR19","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1172\/JCI40096","volume":"120","author":"I Shimizu","year":"2010","unstructured":"Shimizu, I. et al. Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J. Clin. Invest 120, 1506\u20131514 (2010).","journal-title":"J. Clin. Invest"},{"key":"75757_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/nprot.2008.138nprot.2008.138","volume":"3","author":"P Pacher","year":"2008","unstructured":"Pacher, P., Nagayama, T., Mukhopadhyay, P., Batkai, S. & Kass, D. A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422\u20131434. https:\/\/doi.org\/10.1038\/nprot.2008.138nprot.2008.138 (2008).","journal-title":"Nat. Protoc."},{"key":"75757_CR21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/HYPERTENSIONAHA.106.077537","volume":"49","author":"N Koitabashi","year":"2007","unstructured":"Koitabashi, N. et al. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 49, 1120\u20131127. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.106.077537 (2007).","journal-title":"Hypertension"},{"key":"75757_CR22","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.1038\/s41598-022-20520-0","volume":"12","author":"YH Ng","year":"2022","unstructured":"Ng, Y. H. et al. Sarco\/endoplasmic reticulum calcium ATPase activity is unchanged despite increased myofilament calcium sensitivity in Zucker type 2 diabetic fatty rat heart. Sci. Rep. 12, 16904. https:\/\/doi.org\/10.1038\/s41598-022-20520-0 (2022).","journal-title":"Sci. Rep."},{"key":"75757_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s0092-8674(00)81662-1","volume":"99","author":"S Minamisawa","year":"1999","unstructured":"Minamisawa, S. et al. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313\u2013322. https:\/\/doi.org\/10.1016\/s0092-8674(00)81662-1 (1999).","journal-title":"Cell"},{"key":"75757_CR24","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/01.RES.0000129254.25507.d6","volume":"94","author":"DA Kass","year":"2004","unstructured":"Kass, D. A., Bronzwaer, J. G. & Paulus, W. J. What mechanisms underlie diastolic dysfunction in heart failure?. Circ. Res. 94, 1533\u20131542. https:\/\/doi.org\/10.1161\/01.RES.0000129254.25507.d6 (2004).","journal-title":"Circ. Res."},{"key":"75757_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/CIRCRESAHA.108.184408","volume":"104","author":"M Kruger","year":"2009","unstructured":"Kruger, M. et al. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ. Res. 104, 87\u201394. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.184408 (2009).","journal-title":"Circ. Res."},{"key":"75757_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.yjmcc.2010.02.012","volume":"48","author":"M Kruger","year":"2010","unstructured":"Kruger, M., Babicz, K., von Frieling-Salewsky, M. & Linke, W. A. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy. J. Mol. Cell Cardiol. 48, 910\u2013916. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.02.012 (2010).","journal-title":"J. Mol. Cell Cardiol."},{"key":"75757_CR27","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1161\/CIRCRESAHA.114.301286","volume":"114","author":"WA Linke","year":"2014","unstructured":"Linke, W. A. & Hamdani, N. Gigantic business: titin properties and function through thick and thin. Circ. Res. 114, 1052\u20131068. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.301286 (2014).","journal-title":"Circ. Res."},{"key":"75757_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/CIRCULATIONAHA.113.003437CIRCULATIONAHA.113.003437[pii]","volume":"128","author":"N Hamdani","year":"2013","unstructured":"Hamdani, N. & Paulus, W. J. Myocardial titin and collagen in cardiac diastolic dysfunction: partners in crime. Circulation 128, 5\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003437CIRCULATIONAHA.113.003437[pii] (2013).","journal-title":"Circulation"},{"key":"75757_CR29","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1161\/CIRCULATIONAHA.109.860171","volume":"121","author":"MM LeWinter","year":"2010","unstructured":"LeWinter, M. M. & Granzier, H. Cardiac titin: a multifunctional giant. Circulation 121, 2137\u20132145. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.860171 (2010).","journal-title":"Circulation"},{"key":"75757_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/CIRCHEARTFAILURE.113.000539","volume":"6","author":"N Hamdani","year":"2013","unstructured":"Hamdani, N. et al. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ. Heart Fail 6, 1239\u20131249. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000539 (2013).","journal-title":"Circ. Heart Fail"},{"key":"75757_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/01.res.86.1.59","volume":"86","author":"O Cazorla","year":"2000","unstructured":"Cazorla, O. et al. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ. Res. 86, 59\u201367. https:\/\/doi.org\/10.1161\/01.res.86.1.59 (2000).","journal-title":"Circ. Res."},{"key":"75757_CR32","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1161\/CIRCHEARTFAILURE.113.000575","volume":"6","author":"Q Kong","year":"2013","unstructured":"Kong, Q. & Blanton, R. M. Protein kinase G I and heart failure: Shifting focus from vascular unloading to direct myocardial antiremodeling effects. Circ. Heart Fail 6, 1268\u20131283. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000575 (2013).","journal-title":"Circ. Heart Fail"},{"key":"75757_CR33","doi-asserted-by":"publisher","first-page":"108056","DOI":"10.1016\/j.jdiacomp.2021.108056","volume":"36","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Zhou, Y. & Ma, R. Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease. J. Diabetes Complic. 36, 108056. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108056 (2022).","journal-title":"J. Diabetes Complic."},{"key":"75757_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/mt.2008.61","volume":"16","author":"K Niwano","year":"2008","unstructured":"Niwano, K. et al. Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol. Ther. 16, 1026\u20131032. https:\/\/doi.org\/10.1038\/mt.2008.61 (2008).","journal-title":"Mol. Ther."},{"key":"75757_CR35","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1006\/jmcc.2000.1281","volume":"32","author":"Y Wu","year":"2000","unstructured":"Wu, Y., Cazorla, O., Labeit, D., Labeit, S. & Granzier, H. Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. J. Mol. Cell Cardiol. 32, 2151\u20132162. https:\/\/doi.org\/10.1006\/jmcc.2000.1281 (2000).","journal-title":"J. Mol. Cell Cardiol."},{"key":"75757_CR36","doi-asserted-by":"publisher","first-page":"H1007","DOI":"10.1152\/ajpheart.1994.266.3.H1007","volume":"266","author":"DA MacKenna","year":"1994","unstructured":"MacKenna, D. A., Omens, J. H., McCulloch, A. D. & Covell, J. W. Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am. J. Physiol. 266, H1007-1018. https:\/\/doi.org\/10.1152\/ajpheart.1994.266.3.H1007 (1994).","journal-title":"Am. J. Physiol."},{"key":"75757_CR37","doi-asserted-by":"publisher","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","volume":"298","author":"M Sulaiman","year":"2010","unstructured":"Sulaiman, M. et al. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 298, H833-843. https:\/\/doi.org\/10.1152\/ajpheart.00418.2009 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"75757_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/CIRCRESAHA.119.316311","volume":"129","author":"D Soetkamp","year":"2021","unstructured":"Soetkamp, D. et al. Myofilament phosphorylation in stem cell treated diastolic heart failure. Circ. Res. 129, 1125\u20131140. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316311 (2021).","journal-title":"Circ. Res."},{"key":"75757_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.yjmcc.2009.11.013","volume":"48","author":"N Fukuda","year":"2010","unstructured":"Fukuda, N., Terui, T., Ishiwata, S. & Kurihara, S. Titin-based regulations of diastolic and systolic functions of mammalian cardiac muscle. J. Mol. Cell Cardiol. 48, 876\u2013881. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.11.013 (2010).","journal-title":"J. Mol. Cell Cardiol."},{"key":"75757_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1085\/jgp.201812259","volume":"151","author":"RE Slater","year":"2019","unstructured":"Slater, R. E. et al. Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance. J. Gen. Physiol. 151, 42\u201352. https:\/\/doi.org\/10.1085\/jgp.201812259 (2019).","journal-title":"J. Gen. Physiol."},{"key":"75757_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2022.09.002","volume":"173","author":"F Funk","year":"2022","unstructured":"Funk, F. et al. Diabetes disturbs functional adaptation of the remote myocardium after ischemia\/reperfusion. J. Mol. Cell Cardiol. 173, 47\u201360. https:\/\/doi.org\/10.1016\/j.yjmcc.2022.09.002 (2022).","journal-title":"J. Mol. Cell Cardiol."},{"key":"75757_CR42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia, G., Hill, M. A. & Sowers, J. R. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ. Res. 122, 624\u2013638. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311586 (2018).","journal-title":"Circ. Res."},{"key":"75757_CR43","doi-asserted-by":"publisher","first-page":"270ra276","DOI":"10.1126\/scitranslmed.30101347\/270\/270ra6","volume":"7","author":"AM Roberts","year":"2015","unstructured":"Roberts, A. M. et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci. Transl. Med. 7, 270ra276. https:\/\/doi.org\/10.1126\/scitranslmed.30101347\/270\/270ra6 (2015).","journal-title":"Sci. Transl. Med."},{"key":"75757_CR44","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/CIRCRESAHA.108.193326","volume":"104","author":"A Borbely","year":"2009","unstructured":"Borbely, A. et al. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ. Res. 104, 780\u2013786. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.193326 (2009).","journal-title":"Circ. Res."},{"key":"75757_CR45","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.RES.0000143901.37063.2f","volume":"95","author":"I Makarenko","year":"2004","unstructured":"Makarenko, I. et al. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ. Res. 95, 708\u2013716. https:\/\/doi.org\/10.1161\/01.RES.0000143901.37063.2f (2004).","journal-title":"Circ. Res."},{"key":"75757_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms240211321132","author":"F Marino","year":"2023","unstructured":"Marino, F. et al. Streptozotocin-induced type 1 and 2 diabetes mellitus mouse models show different functional, cellular and molecular patterns of diabetic cardiomyopathy. Int. J. Mol. Sci.https:\/\/doi.org\/10.3390\/ijms240211321132 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"75757_CR47","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/s1734-1140(09)70092-1","volume":"61","author":"KA Kaminski","year":"2009","unstructured":"Kaminski, K. A. et al. CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice. Pharmacol. Rep. 61, 496\u2013503. https:\/\/doi.org\/10.1016\/s1734-1140(09)70092-1 (2009).","journal-title":"Pharmacol. Rep."},{"key":"75757_CR48","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1172\/JCI80275","volume":"125","author":"T Nakamura","year":"2015","unstructured":"Nakamura, T. et al. Prevention of PKG1alpha oxidation augments cardioprotection in the stressed heart. J. Clin. Invest. 125, 2468\u20132472. https:\/\/doi.org\/10.1172\/JCI80275 (2015).","journal-title":"J. Clin. Invest."},{"key":"75757_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","volume":"9","author":"N Koitabashi","year":"2011","unstructured":"Koitabashi, N. & Kass, D. A. Reverse remodeling in heart failure\u2013mechanisms and therapeutic opportunities. Nat. Rev. Cardiol. 9, 147\u2013157. https:\/\/doi.org\/10.1038\/nrcardio.2011.172 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"75757_CR50","doi-asserted-by":"publisher","first-page":"e007308","DOI":"10.1161\/CIRCHEARTFAILURE.120.007308","volume":"14","author":"M Fudim","year":"2021","unstructured":"Fudim, M., Sobotka, P. A. & Dunlap, M. E. Extracardiac abnormalities of preload reserve: mechanisms underlying exercise limitation in heart failure with preserved ejection fraction, autonomic dysfunction, and liver disease. Circ. Heart Fail 14, e007308. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007308 (2021).","journal-title":"Circ. Heart Fail"},{"key":"75757_CR51","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.08.2162","volume":"72","author":"TH Marwick","year":"2018","unstructured":"Marwick, T. H. Ejection fraction pros and cons: JACC state-of-the-art review. J. Am. Coll. Cardiol. 72, 2360\u20132379. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.2162 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"75757_CR52","doi-asserted-by":"publisher","first-page":"108935","DOI":"10.1016\/j.celrep.2021.108935","volume":"35","author":"K Gopal","year":"2021","unstructured":"Gopal, K. et al. FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity. Cell Rep. 35, 108935. https:\/\/doi.org\/10.1016\/j.celrep.2021.108935 (2021).","journal-title":"Cell Rep."},{"key":"75757_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1479164117710390","volume":"14","author":"M Tate","year":"2017","unstructured":"Tate, M. et al. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat. Diab. Vasc. Dis. Res. 14, 423\u2013433. https:\/\/doi.org\/10.1177\/1479164117710390 (2017).","journal-title":"Diab. Vasc. Dis. Res."},{"key":"75757_CR54","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1002\/ehf2.13071EHF213071[pii]","volume":"7","author":"T Harada","year":"2020","unstructured":"Harada, T. et al. Pathophysiological role of fatty acid-binding protein 4 in Asian patients with heart failure and preserved ejection fraction. ESC Heart Fail 7, 4256\u20134266. https:\/\/doi.org\/10.1002\/ehf2.13071EHF213071[pii] (2020).","journal-title":"ESC Heart Fail"},{"key":"75757_CR55","doi-asserted-by":"publisher","first-page":"20809","DOI":"10.1038\/s41598-020-77895-12080910.1038\/s41598-020-77895-1[pii]77895[pii]","volume":"10","author":"Y Umbarawan","year":"2020","unstructured":"Umbarawan, Y. et al. Reduced fatty acid uptake aggravates cardiac contractile dysfunction in streptozotocin-induced diabetic cardiomyopathy. Sci. Rep. 10, 20809. https:\/\/doi.org\/10.1038\/s41598-020-77895-12080910.1038\/s41598-020-77895-1[pii]77895[pii] (2020).","journal-title":"Sci. Rep."},{"key":"75757_CR56","doi-asserted-by":"publisher","first-page":"e005565","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","volume":"12","author":"RM Burke","year":"2019","unstructured":"Burke, R. M., Lighthouse, J. K., Mickelsen, D. M. & Small, E. M. Sacubitril\/Valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts. Circ. Heart Fail 12, e005565. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005565 (2019).","journal-title":"Circ. Heart Fail"},{"key":"75757_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00380-020-01711-z","volume":"36","author":"N Furukawa","year":"2021","unstructured":"Furukawa, N. et al. DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism. Heart Vessels 36, 136\u2013146. https:\/\/doi.org\/10.1007\/s00380-020-01711-z (2021).","journal-title":"Heart Vessels"},{"key":"75757_CR58","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/elps.200305392","volume":"24","author":"CM Warren","year":"2003","unstructured":"Warren, C. M., Krzesinski, P. R. & Greaser, M. L. Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins. Electrophoresis 24, 1695\u20131702. https:\/\/doi.org\/10.1002\/elps.200305392 (2003).","journal-title":"Electrophoresis"},{"key":"75757_CR59","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/pr700658q","volume":"7","author":"T Masuda","year":"2008","unstructured":"Masuda, T., Tomita, M. & Ishihama, Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J. Proteome Res. 7, 731\u2013740. https:\/\/doi.org\/10.1021\/pr700658q (2008).","journal-title":"J. Proteome Res."},{"key":"75757_CR60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/abio.1995.1004","volume":"224","author":"R Tatsumi","year":"1995","unstructured":"Tatsumi, R. & Hattori, A. Detection of giant myofibrillar proteins connectin and nebulin by electrophoresis in 2% polyacrylamide slab gels strengthened with agarose. Anal. Biochem. 224, 28\u201331. https:\/\/doi.org\/10.1006\/abio.1995.1004 (1995).","journal-title":"Anal. Biochem."},{"key":"75757_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.mex.2017.09.007","volume":"4","author":"C Zhu","year":"2017","unstructured":"Zhu, C. & Guo, W. Detection and quantification of the giant protein titin by SDS-agarose gel electrophoresis. MethodsX 4, 320\u2013327. https:\/\/doi.org\/10.1016\/j.mex.2017.09.007 (2017).","journal-title":"MethodsX"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75757-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T10:07:13Z","timestamp":1729678033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75757-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75757-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"31 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.K. was supported by a joint research fund from Novartis Pharma, which provided the sacubitril\/valsartan and valsartan used in the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study was reviewed and approved by the Committee of Experimental Animal Research of Gunma University (14\u2013063). All animal models and experimental procedures conformed to the NIH Guide for the Care and Use of Laboratory Animals and the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines (\n                      \n                      ). Euthanasia techniques for experimental animals were performed in accordance with the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals (2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"25081"}}